Biotech

All Articles

Arch finalizes $3B-plus fund to cultivate biopharma startups

.On the heels of a $3 billion fund coming from Bain Funds Lifestyle Sciences, Arch Endeavor Allies i...

Orion to use Aitia's 'digital identical twins' to discover brand new cancer cells medications

.Finnish biotech Orion has actually snooped potential in Aitia's "digital identical twin" tech to bu...

Windtree's surprise med rears blood pressure in newest stage 2 succeed

.While Windtree Therapies has actually battled to increase the economic roots required to make it th...

2 cancer cells biotechs merge, developing worldwide footprint

.OncoC4 is actually taking AcroImmune-- and its internal scientific production functionalities-- und...

Amgen files very first period 3 win for $400M dermatitis medication

.Amgen has actually shared (PDF) the initial stage 3 data on its own $400 thousand eczema medicine, ...

Biogen, UCB record phase 3 lupus succeed after failing earlier test

.Biogen and UCB's bet one's bottom dollar developing in to phase 3 on the back of a broken study loo...

Aptadir hopes new RNA preventions may turn around complicated cancers cells

.Italian biotech Aptadir Therapies has actually released with the pledge that its pipe of preclinica...

Wave surfs DMD success to regulators' doors, sending out stockpile

.Surge Life Sciences has met its target in a Duchenne muscle dystrophy (DMD) research, installing it...

Sanofi tweezes brand-new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is returning to the pharma crease, occupying the...

Achilles splashes cell therapy system, prepares for unemployments after missing 'office feasibility' goals

.Achilles Therapeutics has actually shreded its own strategy. The British biotech is stopping work o...